Clinical Trial

SWEtick - a Prospective Multicenter Study of Tick-borne Diseases in Sweden

Study acronym: SWEtick
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the SWEtick project is to increase the knowledge of the various clinical presentations of emerging tick-borne diseases (eTBD), to assess their importance for human health, to develop and validate laboratory methods for diagnosis of eTBD, and to develop recommendations for knowledge-driven management of patients with suspected eTBD within the Swedish healthcare system.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-16; most recent amendment 2026-03-03.
Trial Details
NCT Number NCT06781008
Lead Sponsor Region Jönköping County
Collaborators: Region Östergötland, Region Kalmar County, Region Dalarna, FORSS - The Research Council of South-Eastern Sweden, ALF Grants, Region Östergötland, Linkoeping University, Region Uppsala, Region Örebro County, Västra Götalandsregionen
Conditions Tick-Borne Diseases
Enrollment 600 participants
Start Date 2023-09-01
Primary Completion 2030-12 (estimated)
Study Completion 2035-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-05